# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-009709
Filing Date
2020-04-24
Accepted
2020-04-24 16:40:12
Documents
4
Period of Report
2020-06-16
Effectiveness Date
2020-04-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | nc10011271x1_def14a.htm | DEF 14A | 517975
2 |  | logo_rocketpharma.jpg | GRAPHIC | 29648
3 |  | nc10011271x1_proxy01.jpg | GRAPHIC | 610610
4 |  | nc10011271x1_proxy02.jpg | GRAPHIC | 669090
| Complete submission text file | 0001140361-20-009709.txt |  | 2321605

Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36829 | Film No.: 20815606
SIC: 2834 Pharmaceutical Preparations